Home | Contact Us | Brochure  | User Guide
0
Username
Password
Forgot Password
Capitaline Newswire App Google Play Capitaline Newswire App Store
02 Apr 2026 00:04 Sensex 73,319.55 185.23 (0.25%) || Nifty 22,713.10 33.70 (0.15%) 00
  AMC
  Single Scheme
  Multi Schemes
  Comparison
  NFO
  Charts
  MF Updates
  Miscellaneous
  Defined Sets
News
Top Equity Holdings by AMC
Interview with Fund Managers Back
14 Jan 2026 18:07
Dr. Reddy's launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7%

Dr. Reddy's Laboratories announced the launch of over-the-counter (OTC) Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7%, the generic equivalent of Extra Strength Pataday® Once-Daily Relief, in the U.S. market, as approved by the U.S. Food and Drug Administration (USFDA).

Dr. Reddy's Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% is an Antihistamine eye drop, indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander.

Powered by Capital Market - Live News
Other Stories
RBL Bank allots 2.33 lakh...
 (2-Apr  19:50)
Aditya Birla Capital allo...
 (2-Apr  19:43)
ICICI Lombard General Ins...
 (2-Apr  19:42)
Board of Zensar Technolog...
 (2-Apr  19:39)
Cupid invests 25% of Rs 3...
 (2-Apr  19:26)
Birlasoft appoints Vikram...
 (2-Apr  17:50)
Emcure Pharmaceuticals re...
 (2-Apr  17:46)
JLR announces wholesale a...
 (2-Apr  17:40)
Emami to acquire balance ...
 (2-Apr  17:38)
LG Electronics India sell...
 (2-Apr  17:36)
  FAQs  |  SEBI  |  AMFI  |  BSE  |  NSE
Glossary  |  Disclaimer   |  Privacy Policy   © Copyright 2022 All rights Reserved. Capital Market Publishers India Pvt. Ltd.